Skip to main content
VCbacked
Log inGet Started

CND Life Sciences

Scottsdale, United States

CND Life Sciences is a life sciences company that develops an evidence-based tool for detecting neurodegenerative diseases.

$13.5M raised
May 2025
Series A
BiotechnologyHealth DiagnosticsLife ScienceMedical

Top Investors

LabCorpMichael J. Fox FoundationVilas VenturesBlueStone Venture PartnersMBX Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CND Life Sciences

How much funding has CND Life Sciences raised?
CND Life Sciences has raised $13.5M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
Who are CND Life Sciences's investors?
CND Life Sciences's investors include LabCorp, Michael J. Fox Foundation, Vilas Ventures, BlueStone Venture Partners, MBX Capital.
Where is CND Life Sciences headquartered?
CND Life Sciences is headquartered in Scottsdale, United States.
What does CND Life Sciences do?
CND Life Sciences is a life sciences company that develops an evidence-based tool for detecting neurodegenerative diseases.
What stage is CND Life Sciences at?
CND Life Sciences is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"CND Life Sciences — Funding & Investors." VCBacked, May 1, 2025, https://www.vcbacked.co/company/cnd-life-sciences. Accessed June 3, 2026.
APA
VCBacked. (2025). CND Life Sciences — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/cnd-life-sciences
Wikipedia (cite web)
{{cite web |title=CND Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/cnd-life-sciences |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong